Genentech, Inc.'s Hedgehog Drug Helps Late-Stage Cancers, Johns Hopkins University, Karmanos Cancer Institute And Translational Genomics Research Institute (TGen) Study
MedPage Today -- More than half of patients with advanced or metastatic basal-cell cancer had major responses to a drug that targets the hedgehog pathway of growth regulation, according to a report in the New England Journal of Medicine.
